The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Pulmonary Arterial Hypertension
Abstract
This review of the mechanism of pulmonary hypertension is focused on pulmonary arterial hypertension, a disorder that can be idiopathic or can occur in association with other disorders, such as infection with the human immunodeficiency virus. The authors suggest that an abnormality involving intracellular signaling mediated by transforming growth factor β underlies the various forms of pulmonary arterial hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320
Clinical classification of pulmonary hypertension
Simonneau, G., Galiè, N., Rubin, L. J., Langleben, D., Seeger, W., Domenighetti, G., Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.037 · Cited by 1,897
Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension
Giaid, A., Yanagisawa, M., Langleben, D., Michel, R. P., Levy, R., Shennib, H., Kimura, S., Masaki, T., Duguid, W. P., & Stewart, D. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282402 · Cited by 1,842
Primary Pulmonary Hypertension
Rubin, L. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360207 · Cited by 1,726
Giaid, A., & Saleh, D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330403 · Cited by 1,369
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Nihon-Kokyuki-Gakkai (2011) · Cited by 1,301
Deng, Z., Morse, J. H., Slager, S. L., Cuervo, N., Moore, K. J., Venetos, G., Kalachikov, S., Cayanis, E., Fischer, S. G., Barst, R. J., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/303059 · Cited by 1,206
Christman, B. W., McPherson, C. D., Newman, J. H., King, G. A., Bernard, G. R., Groves, B. M., & Loyd, J. E. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270202 · Cited by 1,187
Appetite-suppressant drugs and the risk of primary pulmonary hypertension
Abenhaim, L., Moride, Y., Brenot, F., Rich, S., Benichou, J., Kurz, X., Higenbottam, T., Oakley, C., Wouters, E., Aubier, M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350901 · Cited by 1,162
TUDER, R. M., COOL, C. D., GERACI, M. W., WANG, J., ABMAN, S. H., WRIGHT, L., BADESCH, D., & VOELKEL, N. F. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.6.9804054 · Cited by 806
Trembath, R. C., Thomson, J. R., Machado, R. D., Morgan, N. V., Atkinson, C., Winship, I., Simonneau, G., Galie, N., Loyd, J. E., Humbert, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108023450503 · Cited by 725
Liu, F., Ventura, F., Doody, J., & Massagué, J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.7.3479 · Cited by 593
Tuder, R. M., Flook, B. E., & Voelkel, N. F. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117858 · Cited by 588
Eddahibi, S., Humbert, M. J. C., Fadel, É., Raffestin, B., Darmon, M. C., Capron, F., Simonneau, G., Dartevelle, P., Hamon, M., & Adnot, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12805 · Cited by 579
Increased plasma serotonin in primary pulmonary hypertension
Hervé, P., Launay, J.-M., Scrobohaci, M.-L., Brenot, F., Simonneau, G., Petitpretz, P., Poubeau, P., Cerrina, J., Duroux, P., & Drouet, L. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80156-9 · Cited by 560
Primary pulmonary hypertension
Gaine, S. P., & Rubin, L. J. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02111-4 · Cited by 542
Tuder, R. M., Chacon, M., Alger, L., Wang, J., Taraseviciene‐Stewart, L., Kasahara, Y., Cool, C. D., Bishop, A. E., Geraci, M., Semenza, G. L., et al. (2001) · The Journal of Pathology · doi:10.1002/path.953 · Cited by 500
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension
Launay, J.-M., Hervé, P., Peoc'h, K., Tournois, C., Callebert, J., Nebigil, C. G., Etienne, N., Drouet, L., Humbert, M., Simonneau, G., et al. (2002) · Nature Medicine · doi:10.1038/nm764 · Cited by 433
Signaling Molecules in Nonfamilial Pulmonary Hypertension
Du, L., Sullivan, C. C., Chu, D., Cho, A. J., Kido, M., Wolf, P. L., Yuan, J. X.-J., Deutsch, R., Jamieson, S. W., & Thistlethwaite, P. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021650 · Cited by 400
Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease
Aslan, M., Ryan, T. M., Adler, B., Townes, T. M., Parks, D. A., Thompson, J. A., Tousson, A., Gladwin, M. T., Patel, R. P., Tarpey, M. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221292098 · Cited by 391
Primary Pulmonary Hypertension in HIV Infection
Speich, R., Jenni, R., Opravil, M., Pfab, M., & Russi, E. W. (1991) · Chest · doi:10.1378/chest.100.5.1268 · Cited by 354
Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension
Petkov, V., Mosgoeller, W., Ziesche, R., Raderer, M., Stiebellehner, L., Vonbank, K., Funk, G.-C., Hamilton, G., Novotny, C., Burian, B., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17500 · Cited by 352
Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival
Castro, O., Hoque, M., & Brown, B. D. (2003) · Blood · doi:10.1182/blood-2002-03-0948 · Cited by 327
Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1
Foletta, V. C., Lim, M. A., Soosairajah, J., Kelly, A. P., Stanley, E. G., Shannon, M., He, W., Das, S., Massagué, J., & Bernard, O. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200212060 · Cited by 325
Primary Pulmonary Hypertension and Cirrhosis: Are They Related? 1– 3
McDonnell, P. J., Toye, P. A., & Hutchins, G. M. (1983) · American Review of Respiratory Disease · doi:10.1164/arrd.1983.127.4.437 · Cited by 315
Expression of Human Herpesvirus 8 in Primary Pulmonary Hypertension
Cool, C. D., Rai, P. R., Yeager, M. E., Hernandez-Saavedra, D., Serls, A. E., Bull, T. M., Geraci, M. W., Brown, K. K., Routes, J. M., Tuder, R. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035115 · Cited by 294
Castro, M., Krowka, M. J., Schroeder, D. R., Beck, K. C., Plevak, D. J., Rettke, S. R., Cortese, D. A., & Wiesner, R. H. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.6.543 · Cited by 266
Donovan, C. L., Marcovitz, P. A., Punch, J. D., Bach, D. S., Brown, K. A., Lucey, M. R., & Armstrong, W. F. (1996) · Transplantation · doi:10.1097/00007890-199604270-00011 · Cited by 263
Genetic basis of pulmonary arterial hypertension
Newman, J. H., Trembath, R. C., Morse, J. A., Grunig, E., Loyd, J. E., Adnot, S., Coccolo, F., Ventura, C., Phillips, J. A., Knowles, J. A., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.028 · Cited by 247
Regulation of sarcoplasmic reticulum gene expression during cardiac and skeletal muscle development
Arai, M., Otsu, K., MacLennan, D. H., & Periasamy, M. (1992) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1992.262.3.c614 · Cited by 218
Serotonin Transporter Inhibitors Protect against Hypoxic Pulmonary Hypertension
Marcos, E., Adnot, S., Pham, M. H., Nosjean, A., Raffestin, B., Hamon, M., & Eddahibi, S. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1212oc · Cited by 204
Fatal Pulmonary Hypertension Associated with Short-Term Use of Fenfluramine and Phentermine
Mark, E. J., Patalas, E. D., Chang, H. T., Evans, R. J., & Kessler, S. C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708283370904 · Cited by 179
Protective Role of Angiopoietin-1 in Experimental Pulmonary Hypertension
Zhao, Y. D., Campbell, A. I. M., Robb, M., Ng, D., & Stewart, D. J. (2003) · Circulation Research · doi:10.1161/01.res.0000070587.79937.f0 · Cited by 176
Unexplained Pulmonary Hypertension in Chronic Myeloproliferative Disorders
Dingli, D., Utz, J. P., Krowka, M. J., Oberg, A. L., & Tefferi, A. (2001) · Chest · doi:10.1378/chest.120.3.801 · Cited by 175
Prostanoids for Pulmonary Arterial Hypertension
Galiè, N., Manes, A., & Branzi, A. (2003) · American Journal of Respiratory Medicine · doi:10.1007/bf03256644 · Cited by 162
Prevalence of pulmonary hypertension in limited and diffuse scleroderma
Battle, R. W., Davitt, M. A., Cooper, S. M., Buckley, L. M., Leib, E. S., Beglin, P. A., & Tischler, M. D. (1996) · Chest · doi:10.1378/chest.110.6.1515 · Cited by 158
Cardiopulmonary Assessment in Beta-Thalassemia Major
Grisaru, D., Rachmilewitz, E. A., Mosseri, M., Gotsman, M. S., Lafair, J. S., Okon, E., Goldfarb, A., & Hasin, Y. (1990) · CHEST Journal · doi:10.1378/chest.98.5.1138 · Cited by 155
Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease
Klings, E. S., & Farber, H. W. (2001) · Respiratory Research · doi:10.1186/rr70 · Cited by 132
Self-citationPulmonary Hypertension Associated With Long-term Inhalation of “Crank” Methamphetamine
Schaiberger, P. H., Kennedy, T. C., Miller, F. C., Gal, J., & Petty, T. L. (1993) · CHEST Journal · doi:10.1378/chest.104.2.614 · Cited by 130
Hypoxic pulmonary vasoconstriction: role of voltage-gated potassium channels
Sweeney, M., & Yuan, J. X. ‐. (2000) · Respiratory Research · doi:10.1186/rr11 · Cited by 118
Primary Pulmonary Hypertension Associated With the Use of Fenfluramine Derivatives
Simonneau, G., Fartoukh, M. S., Sitbon, O., Humbert, M. J. C., Jagot, J.-L., & Hervé, P. (1998) · CHEST Journal · doi:10.1378/chest.114.3_supplement.195s · Cited by 108
Pulmonary Complications of Sickle Cell Anemia
Minter, K. R., & Gladwin, M. T. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.11.2104101 · Cited by 102
Increased plasma levels of adrenomedullin in patients with pulmonary hypertension
Kakishita, M., Nishikimi, T., Okano, Y., Satoh, T., Kyotani, S., Nagaya, N., Fukushima, K., Nakanishi, N., Takishita, S., Miyata, A., et al. (1999) · Clinical Science · doi:10.1042/cs0960033 · Cited by 99
Stimulant-Induced Pulmonary Toxicity
Albertson, T. E., Walby, W. F., & Derlet, R. W. (1995) · CHEST Journal · doi:10.1378/chest.108.4.1140 · Cited by 97
Rare diseases bullet 5: Primary pulmonary hypertension
Peacock, A. (1999) · Thorax · doi:10.1136/thx.54.12.1107 · Cited by 92
Hypoxic pulmonary vasoconstriction
Dumas, J., Bardou, M., Goirand, F., & Dumas, M. (1999) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(99)00026-9 · Cited by 80
Trell, E., Johansson, B. W., Linell, F., & Ripa, J. (1972) · The American Journal of Medicine · doi:10.1016/0002-9343(72)90115-5 · Cited by 79
Pulmonary Hypertension Secondary to Thrombocytosis in a Patient with Myeloid Metaplasia
Marvin, K. S., & Spellberg, R. D. (1993) · CHEST Journal · doi:10.1378/chest.103.2.642 · Cited by 73
Right ventricular cardiac dysfunction in beta-thalassemia major.
Koren, A., Garty, I., Antonelli, D., et al. (1987) · PubMed · Cited by 42
The erbB/HER type 1 tyrosine kinase receptor family
Walker, R. A. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199807)185:3<313::aid-path93>3.0.co;2-8 · Cited by 38
Lung disease in systemic sclerosis (scleroderma)
Bolster, M. B., & Silver, R. M. (1993) · Baillière s Clinical Rheumatology · doi:10.1016/s0950-3579(05)80269-9 · Cited by 35
Söderman, C., Eriksson, L. S., JUHLIN‐DANNFELT, A., Lundberg, J. M., Broman, L. M., & Holmgren, A. (1993) · Clinical Physiology · doi:10.1111/j.1475-097x.1993.tb00482.x · Cited by 34
Angiopoietin-1 and Pulmonary Hypertension: Cause or Cure?
Rudge, J. S., Thurston, G., & Yancopoulos, G. D. (2003) · Circulation Research · doi:10.1161/01.res.0000074031.94558.99 · Cited by 33
Bioactivity of adrenomedullin and proadrenomedullin N-terminal 20 peptide in man
Nicholls, M. G., Lainchbury, J. G., Lewis, L. K., et al. (2001) · Peptides · doi:10.1016/s0196-9781(01)00508-3 · Cited by 32
Cited by
Holland, A. E., Spruit, M. A., Troosters, T., Puhan, M. A., Pepin, V., Saey, D., McCormack, M. C., Carlin, B. W., Sciurba, F. C., Pitta, F., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00150314 · Cited by 2,530
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension
Galiè, N., Ghofrani, H. A., Torbicki, A., Barst, R. J., Rubin, L. J., Badesch, D., Fleming, T., Parpia, T., Burgess, G., Branzi, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050010 · Cited by 2,476
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
McLaughlin, V. V., Archer, S. L., Badesch, D. B., Barst, R. J., Farber, H. W., Lindner, J. R., Mathier, M. A., McGoon, M. D., Park, M. H., Rosenson, R. S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.01.004 · Cited by 2,360
Self-citationPulmonary Arterial Hypertension in France: Results from a National Registry
Humbert, M., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaici, A., Weitzenblum, E., Cordier, J.-F., Chabot, F., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1668oc · Cited by 2,000
Clinical classification of pulmonary hypertension
Simonneau, G., Galiè, N., Rubin, L. J., Langleben, D., Seeger, W., Domenighetti, G., Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.037 · Cited by 1,897
Metadata
- Authors
- Farber, H. W., & Loscalzo, J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-10-14
- Volume
- 351
- Issue
- 16
- Pages
- 1655-1665
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2614800967
- Cited by
- 1,463
- References
- 56
- FWCI
- 55.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.